Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Immediate Communication
  • Published:

Linkage disequilibrium mapping at DAT1, DRD5 and DBH narrows the search for ADHD susceptibility alleles at these loci

Abstract

Abnormalities in dopaminergic neurotransmission are now accepted as factors in predisposing to ADHD. Evidence of associations between dopamine transporter gene polymorphism and ADHD was first reported by Cook et al. We confirmed the DAT1 association and also identified two additional susceptibility loci at the DRD5 and DBH. Notably, none of the associated variants at these three genes are known to be expressed. Other variants within or closely mapped to the associated alleles are likely to be relevant. In this investigation, we analyse additional markers creating a high-density map across and flanking these genes, and measure intermarker linkage disequilibrium (LD). None of the newly examined markers were more strongly associated with ADHD. At DAT1, the pattern of intermarker LD and haplotype association with the phenotype between exon 9 and the 3′ of the gene suggests that the functional variant at DAT1 may be located to this region. For DRD5, three markers, covering a region of approximately 68 kb including the single DRD5 exon are all associated with disease, and thus do not provide localizing information. However, the data for DBH point to a region close to the centre of the gene. Correlation between D′ and physical distance was observed between markers at DAT1 and DRD5 for distances less than 50 kb. This was not the case for DBH, where LD breakdown was observed between the intron 5 and intron 9 polymorphisms although they are only 9 kb apart. Further genetic analysis is unlikely to refine the location of susceptibility variants and functional assessment of variants within associated regions is required.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Diagram 1
Diagram 2
Diagram 3
Figure 1

Similar content being viewed by others

References

  1. Tannock R . Attention deficit hyperactivity disorder: advances in cognitive, neurobiological and genetic research. J Child Psychol Psychiatry 1998; 39: 65–99.

    Article  CAS  Google Scholar 

  2. Cook Jr EH, Stein MA, Krasowski MD, Cox NJ, Olkon DM, Kieffer JE et al. Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet 1995; 56: 993–998.

    CAS  PubMed  PubMed Central  Google Scholar 

  3. LaHoste GL, Swanson JM, Wigal SB, Glabe C, Wigal T, King N et al. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry 1996; 1: 121–124.

    CAS  PubMed  Google Scholar 

  4. Swanson JM, Sunohara GA, Kennedy JL, Regino R, Fineberg E, Wigal T et al. Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): a family-based approach. Mol Psychiatry 1998; 3: 38–41.

    Article  CAS  Google Scholar 

  5. Gill M, Daly G, Heron S, Hawi Z, Fitzgerald M . Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism. Mol Psychiatry 1997; 2: 311–313.

    Article  CAS  Google Scholar 

  6. Daly G, Hawi Z, Fitzgerald M, Gill M . Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children. Mol Psychiatry 1999; 4: 192–196.

    Article  CAS  Google Scholar 

  7. Tahir E, Yazgan Y, Cirakoglu B, Ozbay F, Waldman I, Asherson P . Association and linkage of DRD4 and DRD5 with attention deficit hyperactivity disorder (ADHD) in a sample of Turkish children. Mol Psychiatry 2000; 5: 396–404.

    Article  CAS  Google Scholar 

  8. Barr CL, Wigg KG, Feng Y, Zai G, Malone M, Roberts W et al. Attention-deficit hyperactivity disorder and the gene for the dopamine D5 receptor. Mol Psychiatry 2000; 5: 548–551.

    Article  CAS  Google Scholar 

  9. Payton A, Holmes J, Barrett JH, Hever T, Fitzpatrick H, Trumper AL et al. Examining for association between candidate gene polymorphisms in the dopamine pathway and attention-deficit hyperactivity disorder: a family-based study. Am J Med Genet (Neuropsych Genet) 2001; 105: 464–470.

    Article  CAS  Google Scholar 

  10. Roman T, Schmitz M, Polanczyk GV, Eizirik M, Rohde LA, Hutz MH . Further evidence for the association between attention-deficit/hyperactivity disorder and the dopamine-beta-hydroxylase gene. Am J Med Genet (Neuropsych Genet) 2002; 114: 154–158.

    Article  Google Scholar 

  11. Risch NJ . Searching for genetics determinants in the new millennium. Nature 2000; 405: 847–856.

    Article  CAS  Google Scholar 

  12. Zhao Z, Jin L, Fu YX, Ramsay M, Jenkins T, Leskinen E et al. Worldwide DNA sequence variation in a 10-kilobase noncoding region on human chromosome 22. Proc Natl Acad Sci USA 2000; 97: 11354–11158.

    Article  CAS  Google Scholar 

  13. Cardon LR, Bell JI . Association study designs for complex diseases. Nat Rev Genet 2001; 2: 91–99.

    Article  CAS  Google Scholar 

  14. Clark AG, Weiss KM, Nickerson DA, Taylor SL, Buchanan A, Stengard J et al. Haplotype structure and population genetic inferences from nucleotide-sequence variation in human lipoprotein lipase. Am J Hum Genet 1998; 63: 595–612.

    Article  CAS  Google Scholar 

  15. Kendler K, MacLean CJ, Ma Y, O'Neill FA, Walsh D, Straub RE et al. Marker to marker linkage disequilibrium on chromosomes 5q, 6p and 8p in Irish Pedigrees. Am J Med Genet (Neuropsych Genet) 1998; 88: 29–33.

    Article  Google Scholar 

  16. Kruglyak L . Prospects for whole-genome linkage disequilibrium mapping of common disease genes. Nat Genet 1999; 22: 139–144.

    Article  CAS  Google Scholar 

  17. Hawi Z, Daly G, Fitzgerald M, Gill M . No association of the dopamine DRD4 receptor gene polymorphisms with the attention deficit hyperactivity disorder (ADHD) in the Irish Population. Am J Med Genet (Neuropsych Genet) 2000; 96: 268–272.

    Article  CAS  Google Scholar 

  18. Ward MF, Wender PH, Reimherr FW . The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry 1993; 150: 885–890.

    Article  CAS  Google Scholar 

  19. Grünhage F, Schulze TG, Müller DJ, Lanczik M, Franzek E, Albus M et al. Systematic screening for DNA sequence variation in the coding region of the human dopamine transporter gene (DAT1). Mol Psychiatry 2000; 5: 275–282.

    Article  Google Scholar 

  20. Greenwood TA, Alexander M, Keck PE, McElroy S, Sadovnick AD, Remick RA et al. Segmental linkage disequilibrium within the dopamine transporter gene. Mol Psychiatry 2002; 7: 165–173.

    Article  CAS  Google Scholar 

  21. Huttley GA, Smith MW, Carrington M, O'Brien SJ . A scan for linkage disequilibrium across the human genome. Genetics 1999; 152: 1711–1722.

    CAS  PubMed  PubMed Central  Google Scholar 

  22. Daly MJ, Rioux JD, Schaffner SF, Hudson TJ, Lander ES . High-resolution haplotype structure in the human genome. Nat Genet 2001; 29: 229–232.

    Article  CAS  Google Scholar 

  23. Goldstein D . Islands of linkage disequilibrium. Nat Genet 2001; 29: 109–111.

    Article  CAS  Google Scholar 

  24. Heinz A, Goldman D, Jones DW, Palmour R, Hommer D, Gorey JG . Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology 2000; 22: 133–139.

    Article  CAS  Google Scholar 

  25. Johnson GC, Esposito L, Barratt BJ, Smith AN, Heward J, Di Genova G et al. Haplotype tagging for the identification of common disease genes. Nat Genet 2001; 29: 233–237.

    Article  CAS  Google Scholar 

  26. Rioux JD, Daly MJ, Silverberg MS, Lindblad K, Steinhart H, Cohen Z et al. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet 2001; 29: 223–228.

    Article  CAS  Google Scholar 

  27. Wei J, Ramchand CN, Hemmings GP . Possible control of dopamine beta-hydroxylase via a codominant mechanism associated with the polymorphic (GT)n repeat at its gene locus in healthy individuals. Hum Genet 1997; 99: 52–55.

    Article  CAS  Google Scholar 

  28. Cubells JF, van Kammen DP, Kelley ME, Anderson GM, O'Connor DT, Price LH et al. Dopamine β-hydroxylase: two polymorphisms in linkage disequilibrium at the structural gene DBH associate with biochemical phenotypic variation. Hum Genet 1998; 102: 533–540.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We acknowledge the generous support of the Health Research Board, Dublin, The Wellcome Trust (AK and ZH), and the Hyperactive and Attention Disorder (HAD) Group Ireland. We also thank the families that participated in the study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Z Hawi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hawi, Z., Lowe, N., Kirley, A. et al. Linkage disequilibrium mapping at DAT1, DRD5 and DBH narrows the search for ADHD susceptibility alleles at these loci. Mol Psychiatry 8, 299–308 (2003). https://doi.org/10.1038/sj.mp.4001290

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.mp.4001290

Keywords

This article is cited by

Search

Quick links